[Federal Register Volume 84, Number 168 (Thursday, August 29, 2019)]
[Notices]
[Page 45523]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-18687]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Registration

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: The registrants listed below have applied for ad been granted 
registration by the Drug Enforcement Administration (DEA) as importers 
of schedule I and II controlled substances.

SUPPLEMENTARY INFORMATION: The companies listed below applied to be 
registered as an importers of various basic classes of schedule I and 
II controlled substances. Information on previously published notices 
is listed in the table below. No comments or objections were submitted 
and no requests for a hearing were submitted for these notices.

----------------------------------------------------------------------------------------------------------------
                   Companies                               FR docket                        Published
----------------------------------------------------------------------------------------------------------------
Mylan Pharmaceuticals Inc.....................  84 FR 18321....................  April 30, 2019.
Rhodes Technologies...........................  84 FR 21807....................  May 15, 2019.
S & B Pharma, Inc.............................  84 FR 21813....................  May 15, 2019.
Wildlife Laboratories, Inc....................  84 FR 21809....................  May 15, 2019.
----------------------------------------------------------------------------------------------------------------

    The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 
958(a) and determined that the registration of the listed registrants 
to import the applicable various basic classes of schedule I and II 
controlled substances is consistent with the public interest and with 
United States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971. The DEA investigated each of the 
company's maintenance of effective controls against diversion by 
inspecting and testing each company's physical security systems, 
verifying each company's compliance with state and local laws, and 
reviewing each company's background and history.
    Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the DEA has granted a registration as 
an importer for schedule II controlled substances to the above listed 
companies.

    Dated: August 16, 2019.
Neil D. Doherty,
Acting Assistant Administrator.
[FR Doc. 2019-18687 Filed 8-28-19; 8:45 am]
 BILLING CODE 4410-09-P